Our Goal

Advance innovation in clinical trials by promoting, measuring, and assessing clinical trial patient participant experience among drug development professionals.

US Population Participation in Clinical Trials

The National Institute of Health found that under 5% of adult US oncology patients participated in a clinical trial

Diversity in Clinical Trials

♦ African‐Americans represent 12% of the U.S. population but only 5% of clinical trial participants ♦ Hispanics make up 16% of the population but only 1% of clinical trial participants ♦ Sex distribution in cardiovascular device trials is 67% male

Drug Development Professionals Participation in Clinical Trials

Has never been studied. Until now!

Our Operating hypothesis

First-hand patient participant experience in clinical studies among those empowered to innovate in clinical trials—drug developers—can positively impact the speed, safety, and quality of study conduct, as well as the effectiveness of patient enrollment and retainment practices